4.6 Article

Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Increased co-expression of MEST and BRCA1 is associated with worse prognosis and immune infiltration in ovarian cancer

Jing Zhang et al.

Summary: This study investigated the expression pattern of MEST in ovarian cancer and its association with immune cell infiltration, finding that high MEST expression was associated with diminished immune cell infiltration and worse prognosis in patients.

GYNECOLOGIC ONCOLOGY (2022)

Review Cell Biology

Cancer biology deciphered by single-cell transcriptomic sequencing

Yanmeng Li et al.

Summary: Recent studies utilizing single-cell RNA sequencing have provided novel insights into cancer biology, particularly in understanding cancer stem-cell model, treatment resistance, and cancer metastasis. Additionally, this technology has portrayed the diverse cell types and complex cellular states in the tumor microenvironment, offering potential for discovering new targets for future immunotherapy.

PROTEIN & CELL (2022)

Article Oncology

The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer

Sihui Yu et al.

Summary: Cervical cancer is a common gynecological malignancy, and developing reliable prognostic models is important for personalized treatment. In this study, a metabolism-related signature was identified for prognosis and anti-tumor immunity in cervical cancer. Patients with a high-risk score had worse prognosis and lower infiltration of tumor infiltrating lymphocytes. The risk score model also predicted prognosis based on expression of immune checkpoints. This study provides an effective prognostic tool for personalized treatment.

CANCERS (2022)

Review Physiology

DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS

Giulia Biffi et al.

Summary: Efforts to develop anti-cancer therapies have mainly targeted the epithelial compartment, but recent studies have shown the significant influence of cancer-associated fibroblasts (CAFs) in tumor progression. CAFs not only promote cancer cell proliferation, therapy resistance, and immune exclusion, but may also restrain tumor progression in certain contexts. Research on CAFs has focused on their heterogeneity, plasticity, and functions across different cancer types and states, as well as advancements in therapeutic strategies targeting CAFs currently undergoing preclinical and clinical evaluation.

PHYSIOLOGICAL REVIEWS (2021)

Review Oncology

Macrophage-Based Approaches for Cancer Immunotherapy

Nicholas R. Anderson et al.

Summary: Adoptive cell therapy with genetically modified T cells has shown promising results in hematologic malignancies, but applying it to solid tumors has been challenging. This has led to the investigation of alternative immune cells as therapeutic options. Macrophages have functional plasticity that can be harnessed for both antitumor and protumor effects, leading to efforts to deplete or repolarize tumor-associated macrophages, as well as exploring the potential of adoptively transferring genetically modified macrophages.

CANCER RESEARCH (2021)

Review Oncology

Tumor-associated macrophage-targeted therapeutics in ovarian cancer

Yuanyuan An et al.

Summary: Ovarian cancer is influenced significantly by the tumor microenvironment, where macrophages play a crucial role in regulating the progression of the disease. Targeted therapy focusing on macrophages shows promise in treating ovarian cancer, despite facing challenges. Interactions between macrophages and other immune cells within the microenvironment also impact the development of ovarian cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Review Oncology

Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers

Tianhan Xu et al.

Summary: Tumor-associated macrophages (TAMs) play a key role in regulating gynecological and breast cancers by influencing cancer cell proliferation, tumor angiogenesis, and tumor-related immunosuppression. Targeting TAMs with potential drugs may be an effective therapeutic strategy in the future.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis

Gao Liu et al.

Summary: CAFs-derived cytokines can enhance hepatocellular carcinoma progression and metastasis by activating the circRNA-miRNA-mRNA axis in tumor cells, with CXCL11 playing a key role in this process.

CELL DEATH & DISEASE (2021)

Article Oncology

Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway

Shuhai Chen et al.

Summary: This study found that in hepatocellular carcinoma, CAFs promote M2 polarization of TAMs and induce secretion of PAI-1 via CXCL12, enhancing the malignant behavior of HCC cells.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Review Oncology

Therapeutic targeting of the hypoxic tumour microenvironment

Dean C. Singleton et al.

Summary: The article discusses the relationship between two different tumor microenvironment research fields: physicochemical gradients and cellular interactions, with a focus on translational therapeutic opportunities. Hypoxia is a common feature of tumors, influencing various cancer characteristics and responses to anticancer therapies.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Immunology

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer

Sihui Yu et al.

Summary: A predictive model based on immune infiltration-related gene signature was proposed to predict the prognosis of cervical cancer patients and depict the immune landscape. Analysis of 28 immune cell types identified four immune cell types conducive to patient survival and confirmed their shared differentially expressed genes. The Immunoscore based on four immune-related genes could effectively predict the survival outcome, tumor infiltration status, and immunotherapy efficacy of cervical cancer patients.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

Gurcan Gunaydin

Summary: CAFs and TAMs are crucial players in the tumor microenvironment, playing key roles in tumor growth and progression. They have intricate interactions with each other and with tumor cells, impacting tumor progression and immune evasion. Understanding these interactions may lead to the development of novel therapeutic targets for cancer.

FRONTIERS IN ONCOLOGY (2021)

Review Medicine, Research & Experimental

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming

Zhenzhen Li et al.

Summary: Cancer cells adapt their metabolism to proliferate and survive in harsh environments, with a close relationship between tumor microenvironment and cancer-associated fibroblasts (CAFs) playing key roles in tumor growth and metastasis. CAFs act as major regulators in shaping tumor metabolism, especially through dysregulation of metabolic pathways, influencing cancer cell behavior and response to therapy. The interaction and crosstalk between cancer cells and CAFs contribute to metabolic reprogramming that impacts cancer cell growth and progression.

THERANOSTICS (2021)

Article Biochemistry & Molecular Biology

TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment

Dongqing Sun et al.

Summary: Cancer immunotherapy targeting co-inhibitory pathways by checkpoint blockade has shown significant efficacy, but only a minority of patients respond due to tumor microenvironment heterogeneity. TISCH is a large curated database that integrates single-cell transcriptomic profiles from 76 high-quality tumor datasets across 27 cancer types, providing a user-friendly interface for exploring gene expression atlas in the TME from multiple cancer types.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer

Haiyang Zhang et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Biochemistry & Molecular Biology

Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer

Katarzyna Ratajczak-Wielgomas et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

Neel I. Nissen et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Gastroenterology & Hepatology

Cancer-associated fibroblasts in gastrointestinal cancer

Hiroki Kobayashi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Oncology

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

Tongyan Liu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Article Multidisciplinary Sciences

LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment

Changhao Chen et al.

NATURE COMMUNICATIONS (2018)

Editorial Material Oncology

CAFs and TAMs: maestros of the tumour microenvironment

Yoshihiro Komohara et al.

JOURNAL OF PATHOLOGY (2017)

Article Biochemistry & Molecular Biology

Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression

Zongyuan Yang et al.

MOLECULAR CANCER (2017)

Article Oncology

Immunotherapy in ovarian cancer

K. Odunsi

ANNALS OF ONCOLOGY (2017)

Article Obstetrics & Gynecology

Epidemiology of epithelial ovarian cancer

Penelope M. Webb et al.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

Article Oncology

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

Richard W. Tothill et al.

CLINICAL CANCER RESEARCH (2008)

Article Pharmacology & Pharmacy

Quantitative analysis of FMO gene mRNA levels in human tissues

J Zhang et al.

DRUG METABOLISM AND DISPOSITION (2006)